The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Amyloid-β-Induced Astrocytic Phagocytosis is Mediated by CD36, CD47 and RAGE
Abstract
Astrocytes, the most numerous glial cell in the brain, have multiple functions and are key to maintenance of homeostasis in the central nervous system. Microglia are the resident immunocompetent cells in the brain and share several functions with macrophages, including their phagocytic ability. Indeed microglia are the resident phagocytes in the brain and express numerous cell surface proteins which act to enable receptor-mediated phagocytosis. However recent evidence suggests that astrocytes express some genes which permit phagocytosis of phosphatidylserine-decorated cells and this probably explains sporadic reports in the literature which suggest that astrocytes become phagocytic following brain trauma. Here we examined the potential of astrocytes to phagocytose fluorescently-labelled latex beads and amyloid-β (Aβ) and report that they competently engulf both in a manner that relies on actin polymerization since it was inhibited by cytochalasin D. The data indicate that incubation of cultured astrocytes or microglia with Aβ increased phagocytosis and markers of activation of both cell types. Aβ was found to markedly increase expression of the putative Aβ-binding receptors CD36 and CD47 in astrocytes, while it decreased expression of the receptor for advanced glycation endproducts (RAGE). It is demonstrated that blocking these receptors using a neutralizing antibody attenuated Aβ-induced phagocytosis of latex beads by astrocytes. Interestingly blocking these receptors also decreased uptake of beads even in the absence of Aβ. Here we demonstrate that astrocytes are competent phagocytes and are capable of engulfing Aβ.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Blocking receptors including CD36, CD47, and RAGE with neutralizing antibodies can attenuate astrocytic phagocytosis of Aβ, implicating they are putative Aβ receptors in astrocytes [407].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [407]
Citations
Cites
Cahoy, J. D., Emery, B., Kaushal, A., Foo, L. C., Zamanian, J. L., Christopherson, K. S., Xing, Y., Lubischer, J. L., Krieg, P. A., Krupenko, S. A., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4178-07.2008 · Cited by 3,129
Microglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice
Hickman, S. E., Allison, E. K., & El Khoury, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0616-08.2008 · Cited by 1,329
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265
El Khoury, J., Toft, M., Hickman, S. E., Means, T. K., Terada, K., Geula, C., & Luster, A. D. (2007) · Nature Medicine · doi:10.1038/nm1555 · Cited by 915
Adult mouse astrocytes degrade amyloid-β in vitro and in situ
Wyss-Coray, T., Loike, J. D., Brionne, T. C., Lu, E., Anankov, R., Yan, F., Silverstein, S. C., & Husemann, J. (2003) · Nature Medicine · doi:10.1038/nm838 · Cited by 909
Streit, W. J., Braak, H., Xue, Q.-S., & Bechmann, I. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0556-6 · Cited by 727
The role of microglia in amyloid clearance from the AD brain
Lee, C. Y. D., & Landreth, G. E. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0433-4 · Cited by 701
Functions and molecular mechanisms of the CD47–SIRPα signalling pathway
Matozaki, T., Murata, Y., Okazawa, H., & Ohnishi, H. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.12.001 · Cited by 481
Koenigsknecht-Talboo, J., & Landreth, G. E. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1808-05.2005 · Cited by 477
Microglial Phagocytosis of Fibrillar β-Amyloid through a β1Integrin-Dependent Mechanism
Koenigsknecht-Talboo, J., & Landreth, G. E. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.2557-04.2004 · Cited by 455
Cited by
Sorted by citations
Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
Guo, T., Zhang, D., Zeng, Y., Huang, T. Y., Xu, H., & Zhao, Y. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00391-7 · Cited by 994
“Blocking receptors including CD36, CD47, and RAGE with neutralizing antibodies can attenuate astrocytic phagocytosis of Aβ, implicating they are putative Aβ receptors in astrocytes [407].”
BackgroundAstrocyte roles in traumatic brain injury
Burda, J. E., Bernstein, A. M., & Sofroniew, M. V. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.03.020 · Cited by 791
“Intriguingly, amyloid-β mediated activation of astrocyte RAGE stimulates astrocytes themselves to become phagocytic and engulf extracellular amyloid-β (Jones et al., 2013), possibly implicating reactive astrocytes in the clearance of neuro- and gliotoxic amyloid protein after injury.”
BackgroundLian, H., Litvinchuk, A., Chiang, A. C.-A., Aithmitti, N., Jankowsky, J. L., & Zheng, H. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.2117-15.2016 · Cited by 597
“Microglial uptake of both artificial substrates such as fluorescent latex beads and more realistic targets such as synthetic A 42 aggregates is accomplished through phagocytosis (Koenigsknecht and Landreth, 2004; Smith et al., 2010; Jones et al., 2013).”
BackgroundGonzález-Reyes, R. E., Nava-Mesa, M. O., Vargas-Sánchez, K., Ariza-Salamanca, D. F., & Mora-Muñoz, L. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00427 · Cited by 541
“Furthermore, astrocytes have been reported to adopt a phagocytic profile capable of engulfing A β , mediated by CD36, CD47, and RAGE receptors (Jones et al., 2013).”
BackgroundMechanisms of Aβ Clearance and Degradation by Glial Cells
Ries, M., & Sastre, M. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00160 · Cited by 527
“Although RAGE receptors have been mainly involved in mediating the inflammatory cascade in activated microglia (Solito and Sastre, 2012), their role in Aβ phagocytosis in astrocytes has been recently demonstrated when blocking these receptors with specific antibodies (Jones et al., 2013).”
BackgroundHuman Astrocytes Transfer Aggregated Alpha-Synuclein via Tunneling Nanotubes
Rostami, J., Holmqvist, S., Lindström, V., Sigvardson, J., Westermark, G. T., Ingelsson, M., Bergström, J., Roybon, L., & Erlandsson, A. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.0983-17.2017 · Cited by 339
“Reactive astrocytes effectively engulf dead cells, synapses, and protein aggregates of amyloid (A ) and -SYN (Chang et al., 2000; Magnus et al., 2002; Sokolowski et al., 2011; Lööv et al., 2012; Chung et al., 2013; Fellner et al., 2013; Jones et al., 2013; Söllvander et al., 2016).”
BackgroundUpadhya, R., Zingg, W., Shetty, S., & Shetty, A. K. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.04.017 · Cited by 282
Söllvander, S., Nikitidou, E., Brolin, R., Söderberg, L., Sehlin, D., Lannfelt, L., & Erlandsson, A. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0098-z · Cited by 267
Astrocyte dysfunction in Alzheimer disease
Acosta, C., Anderson, H. D., & Anderson, C. M. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24075 · Cited by 261
“Cultured astrocytes engulf amyloid b by a process dependent on amyloid b– binding receptors CD36 and CD47 (Jones et al., 2013).”
BackgroundMicroglial Aβ Receptors in Alzheimer’s Disease
Yu, Y., & Ye, R. D. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0101-6 · Cited by 247
Extracellular protein components of amyloid plaques and their roles in Alzheimer’s disease pathology
Rahman, M. M., & Lendel, C. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00465-0 · Cited by 255
Phagocytic clearance of presynaptic dystrophies by reactive astrocytes in Alzheimer's disease
Gomez‐Arboledas, A., Davila, J. C., Sanchez‐Mejias, E., Navarro, V., Nuñez‐Diaz, C., Sanchez‐Varo, R., Sanchez‐Mico, M. V., Trujillo‐Estrada, L., Fernandez‐Valenzuela, J. J., Vizuete, M., et al. (2018) · Glia · doi:10.1002/glia.23270 · Cited by 220
de Godoy, M. A., Saraiva, L. M., de Carvalho, L. R. P., Vasconcelos-dos-Santos, A., Beiral, H. J. V., Ramos, A. B., Silva, L. R. D. P., Leal, R. B., Monteiro, V. H. S., Braga, C. V., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.807180 · Cited by 214
“On the other hand, recent evidence indicates that phagocytosis of A by astrocytes is mediated by CD36, CD47, and RAGE receptors (51).”
BackgroundRustenhoven, J., Aalderink, M., Scotter, E. L., Oldfield, R. L., Bergin, P. S., Mee, E. W., Graham, E. S., Faull, R. L. M., Curtis, M. A., Park, T. I.-H., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0503-0 · Cited by 201
“TGFβ1 reduces gene expression of scavenger receptors Scavenger receptors have a key role in recognising and coordinating the uptake of a wide range of macromolecules, including fluorescent beads and disease related proteins such as amyloid beta [48, 49].”
BackgroundZeller, M. V., Dias, D., Sebastião, A. M., & Valente, C. A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210268 · Cited by 179
Role of lipid microdomains in TLR-mediated signalling
Ruysschaert, J., & Lonez, C. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.03.014 · Cited by 149
Wang, Z., Zhao, Y., Xu, N., Zhang, S., Wang, S., Mao, Y., Zhu, Y., Li, B. J., Jiang, Y., Tan, Y. C., et al. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03074-9 · Cited by 137
Tao, L., Liu, Q., Zhang, F., Fu, Y., Zhu, X. D., Weng, X., Han, H., Huang, Y., Suo, Y., Chen, L., et al. (2021) · Light Science & Applications · doi:10.1038/s41377-021-00617-3 · Cited by 133
Inflammasomes as therapeutic targets for A lzheimer's disease
White, C., Lawrence, C. B., Brough, D., & Rivers‐Auty, J. (2016) · Brain Pathology · doi:10.1111/bpa.12478 · Cited by 136
“No drugs have currently been established to directly bind and inhibit the NLRP3 inflammasome, however, the essential processes for NLRP3 activation of VRAC activation has been targeted using currently indicated fenamate NSAIDs and these were found to be therapeutic in four separate animal models of AD (35,68,153).”
MethodMicroglial phagocytosis in aging and Alzheimer's disease
Gabandé‐Rodríguez, E., Keane, L., & Capasso, M. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24419 · Cited by 127
Minogue, A. M., Jones, R. S., Kelly, R. J., McDonald, C., Connor, T. J., & Lynch, M. A. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.12.026 · Cited by 111
“Flow cytometry was carried out as previously described (Jones et al., 2013), with the exception that cells were blocked in FACS”
MethodSelf-citationMicroglia and Astrocytes in Alzheimer’s Disease: Significance and Summary of Recent Advances
Deng, Q., Wu, C., Parker, E., Liu, T. C.-Y., Duan, R., & Yang, L. (2023) · Aging and disease · doi:10.14336/ad.2023.0907 · Cited by 102
Couturier, J., Stancu, I., Schakman, O., Pierrot, N., Huaux, F., Kienlen‐Campard, P., Dewachter, I., & Octave, J. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0477-y · Cited by 95
“Recent studies have shown an Aβ-induced phagocytosis of latex beads [25] as well as direct engulfment of Aβ [26].”
BackgroundAmyloid‐β impairs the phagocytosis of dystrophic synapses by astrocytes in Alzheimer's disease
Sanchez‐Mico, M. V., Jimenez, S., Gomez‐Arboledas, A., Muñoz‐Castro, C., Romero‐Molina, C., Navarro, V., Sanchez‐Mejias, E., Nuñez‐Diaz, C., Sanchez‐Varo, R., Galea, E., et al. (2021) · Glia · doi:10.1002/glia.23943 · Cited by 93
Prantner, D., Nallar, S., & Vogel, S. N. (2020) · The FASEB Journal · doi:10.1096/fj.202002136r · Cited by 92
Phagocytic Roles of Glial Cells in Healthy and Diseased Brains
Jung, Y.-J., & Chung, W.-S. (2018) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.133 · Cited by 89
“Microglia mediate the clearance of Aβ through receptor-mediated phagocytosis via the use of advance glycation end products (RAGE), toll-like receptors 2 (TLR2) and 4 (TLR4), scavenger receptor CD36, PS receptor and purine receptor P2Y6 (Noda and Suzumura, 2012; Jones et al., 2013).”
BackgroundRecent insights on astrocyte mechanisms in CNS homeostasis, pathology, and repair
Hart, C. G., & Karimi‐Abdolrezaee, S. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24922 · Cited by 88
Fanlo-Ucar, H., Picón-Pagès, P., Herrera-Fernández, V., ILL‐Raga, G., & Muñoz, F. J. (2024) · Antioxidants · doi:10.3390/antiox13101208 · Cited by 89
Astrocytes: Heterogeneous and Dynamic Phenotypes in Neurodegeneration and Innate Immunity
Cunningham, C. M., Dunne, A., & López-Rodríguez, A. B. (2018) · The Neuroscientist · doi:10.1177/1073858418809941 · Cited by 78
CD36 in Alzheimer’s Disease: An Overview of Molecular Mechanisms and Therapeutic Targeting
Dobri, A.-M., Dudău, M., Enciu, A., & Hinescu, M. E. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.11.003 · Cited by 83
“Although astrocytes do not express CD36 in resting conditions, they can upregulate it when treated with Ab peptides (Jones et al., 2013).”
BackgroundGlial Modulators as Potential Treatments of Psychostimulant Abuse
Beardsley, P. M., & Hauser, K. F. (2014) · Advances in pharmacology · doi:10.1016/b978-0-12-420118-7.00001-9 · Cited by 84
Loeffler, D. A. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-230025 · Cited by 88
Ullah, R., Park, T. J., Huang, X., & Kim, M. O. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101451 · Cited by 78
“(Jones et al., 2013; Ries and Sastre, 2016), formyl peptide receptors (FPRs) (Brandenburg”
Astroglial Responses to Amyloid-Beta Progression in a Mouse Model of Alzheimer’s Disease
Olsen, M., Aguilar, X., Sehlin, D., Fang, X. T., Antoni, G., Erlandsson, A., & Syvänen, S. (2018) · Molecular Imaging and Biology · doi:10.1007/s11307-017-1153-z · Cited by 77
Xie, Z., Zhao, J., Wang, H., Jiang, Y., Yang, Q., Fu, Y., Zeng, H., Hölscher, C., Xu, J., & Zhang, Z. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.109886 · Cited by 78
Li, M., Ji, J., Zheng, L.-J., Shen, J., Li, X., Zhang, Q., Bai, X., & Wang, Q. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.239449 · Cited by 74
“…throughout all brain regions, so they can effectively clear Aβ from the brain, and they are susceptible to oligomeric Aβ (Nielsen et al., 2010; Jones et al., 2013), which highly correlates with markers of disease severity and is toxic to the central nervous system (McLean et al., 1999;…”
BackgroundCNS-Draining Meningeal Lymphatic Vasculature: Roles, Conundrums and Future Challenges
das Neves, S. P., Delivanoglou, N., & Mesquita, S. D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.655052 · Cited by 70
“…by enzymes (Qiu et al., 1998; Farris et al., 2003; HernandezGuillamon et al., 2015), phagocytosis by microglia and astrocytes (Weldon et al., 1998; Jones et al., 2013), receptormediated excretion across the BBB (Shibata et al., 2000; Silverberg et al., 2010), and perivascular efflux into…”
BackgroundHuman Alzheimer’s disease reactive astrocytes exhibit a loss of homeostastic gene expression
Dai, D. L., Li, M., & Lee, E. B. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01624-8 · Cited by 77
Slow degradation in phagocytic astrocytes can be enhanced by lysosomal acidification
Lööv, C., Mitchell, C. H., Simonsson, M., & Erlandsson, A. (2015) · Glia · doi:10.1002/glia.22873 · Cited by 71
“Discussion Phagocytosis by astrocytes has been described in several studies (Chang et al., 2000; Chung et al., 2013; Fellner et al., 2013; Jones et al., 2013; Loov et al., 2012; Magnus et al., 2002; Sokolowski et al., 2011), but the molecular mechanisms of astrocyte degradation remain elusive.”
Söllvander, S., Nikitidou, E., Streubel-Gallasch, L., Zyśk, M., Söderberg, L., Sehlin, D., Lannfelt, L., & Erlandsson, A. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1134-4 · Cited by 72
Pathophysiology of Lipid Droplets in Neuroglia
Smolič, T., Zorec, R., & Vardjan, N. (2021) · Antioxidants · doi:10.3390/antiox11010022 · Cited by 73
“Fatty acid translocase (FAT/CD36) FAT Increased expression upon treatment with amyloid-β [50].”
BackgroundCrespo‐Castrillo, A., & Arévalo, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093219 · Cited by 65
Lasing in Live Mitotic and Non-Phagocytic Cells by Efficient Delivery of Microresonators
Schubert, M., Volckaert, K., Karl, M., Morton, A., Liehm, P., Miles, G. B., Powis, S. J., & Gather, M. C. (2017) · Scientific Reports · doi:10.1038/srep40877 · Cited by 59
A role of low-density lipoprotein receptor-related protein 4 (LRP4) in astrocytic Aβ clearance
Zhang, H., Chen, W., Tan, Z., Zhang, L., Dong, Z., Cui, W., Zhao, K., Wang, H., Jing, H., Cao, R., et al. (2020) · The Journal of Neuroscience · doi:10.1523/jneurosci.0250-20.2020 · Cited by 58
“…soluble and insoluble Ab (Wisniewski and Wegiel, 1991; Funato et al., 1998; Wyss-Coray et al., 2003; Nielsen et al., 2009; Chung et al., 2013; Jones et al., 2013; R. X. Liu et al., 2016) and degrade them via the late endolysosomal pathway (Shaffer et al., 1995; Wyss-Coray et al., 2003;…”
BackgroundCampos-Peña, V., Toral-Rios, D., Becerril-Pérez, F., Sánchez-Torres, C., Delgado-Namorado, Y., Torres-Ossorio, E., Franco-Bocanegra, D., & Carvajal, K. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6768 · Cited by 58
Targeting Alzheimer’s disease with multimodal polypeptide-based nanoconjugates
Duro‐Castaño, A., Borrás, C., Herranz‐Pérez, V., Blanco-Gandía, M. C., Conejos‐Sánchez, I., Armiñán, A., Mas‐Bargues, C., Inglés, M., Miñarro, J., Rodríguez‐Arias, M., et al. (2021) · Science Advances · doi:10.1126/sciadv.abf9180 · Cited by 56
Targeting MicroRNA-485-3p Blocks Alzheimer’s Disease Progression
Koh, H., Lee, S., Lee, H., Min, J.-W., Iwatsubo, T., Teunissen, C. E., Cho, H., & Ryu, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313136 · Cited by 55
de Retana, S. F., Marazuela, P., Solé, M., Colell, G., Bonaterra‐Pastra, A., Sánchez‐Quesada, J. L., Montaner, J., Maspoch, D., Cano‐Sarabia, M., & Hernández‐Guillamón, M. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0498-8 · Cited by 55
Thrombospondin-1 in maladaptive aging responses: a concept whose time has come
Isenberg, J. S., & Roberts, D. D. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00089.2020 · Cited by 51
T Cells—Protective or Pathogenic in Alzheimer’s Disease?
McManus, R. M., Mills, K. H. G., & Lynch, M. A. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9612-2 · Cited by 54
“…that these cells express TLRs and pattern recognition receptors (PRRs) (Bowman et al. 2003; Jack et al. 2005), are capable of phagocytosis, including phagocytosis of Aβ (Jones et al. 2013) and can produce pro-inflammatory cytokines upon activation (Chastain et al. 2011; Dong and Benveniste 2001).”
BackgroundSelf-citationGustafsson, G., Lindström, V., Rostami, J., Nordström, E. K. L., Lannfelt, L., Bergström, J. J. E., Ingelsson, M., & Erlandsson, A. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-1018-z · Cited by 48
Wang, X., Zhang, X., Zhou, T.-T., Li, N., Jang, C.-Y., Xiao, Z., Ma, Q., & Li, S. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00094 · Cited by 45
“Lyophilized Aβ1−42 peptide (SIGMA, A9810) and reverse peptide Aβ42−1 (SIGMA, SCP0048) were diluted to 1mg/ml using sterile PBS and incubated at 37◦C, 220 rpm for 48 h allowed to aggregate as described (Jones et al., 2013).”
MethodMonitoring phagocytic uptake of amyloid β into glial cell lysosomes in real time
Prakash, P., Jethava, K. P., Korte, N., Izquierdo, P., Favuzzi, E., Rose, I. V. L., Guttenplan, K. A., Manchanda, P., Dutta, S., Rochet, J.-C., et al. (2021) · Chemical Science · doi:10.1039/d1sc03486c · Cited by 45
Activated Scavenger Receptor A Promotes Glial Internalization of Aβ
Zhang, H., Su, Y., Zhou, W.-W., Wang, S.-W., Xu, P., Yu, X., & Liu, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094197 · Cited by 43
“Aside from microglia, astrocytes are also considered main phagocytes that can engulf Ab [20].”
BackgroundPotential neurotoxic activity of diverse molecules released by astrocytes
Murray, T. E., Richards, C. M., Robert-Gostlin, V. N., Bernath, A. K., Lindhout, I. A., & Klegeris, A. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.08.015 · Cited by 40
Tajbakhsh, A., Read, M. I., Barreto, G. E., Ávila-Rodriguez, M., Hayat, S. M. G., & Sahebkar, A. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173873 · Cited by 41
Durand, D., Carniglia, L., Turati, J., Ramírez, D., Saba, J., Caruso, C. M., & Lasaga, M. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.05.008 · Cited by 41
“In addition, individual neutralization of CD36, CD47, or RAGE in astrocytes partially inhibits their phagocytic capability (Jones et al., 2013).”
Crespo‐Castrillo, A., García‐Segura, L. M., & Arévalo, M. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-1719-6 · Cited by 40
Yuan, D., Yang, G., Wu, W., Li, Q., Xu, D.-E., Ntim, M., Jiang, C., Liu, J.-C., Zhang, Y., Wang, Y., et al. (2022) · Aging Cell · doi:10.1111/acel.13593 · Cited by 39
Heme and hemoglobin suppress amyloid β–mediated inflammatory activation of mouse astrocytes
Sankar, S. B., Donegan, R. K., Shah, K. J., Reddi, A. R., & Wood, L. B. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.001050 · Cited by 38
“Aβ is highly promiscuous (47) although key astrocyte scavenger receptors include CD36, RAGE, and CD47 (48).”
BackgroundNazareth, L., John, J. A. S., Murtaza, M., & Ekberg, J. A. K. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.660259 · Cited by 42
Koerich, S., Parreira, G. M., de Almeida, D. L., Vieira, R. P., & de Oliveira, A. C. P. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220922153903 · Cited by 40
“Additionally, astrocytes have demonstrated a RAGE-mediated phagocytic ability to engulf Aβ [102].”
Hirota, Y., Sakakibara, Y., Ibaraki, K., Takei, K., Iijima, K., & Sekiya, M. (2022) · Brain Communications · doi:10.1093/braincomms/fcac286 · Cited by 40
Lv, J., Ma, S., Zhang, X., Zheng, L., Ma, Y., Zhao, X., Lai, W., Shen, H., Wang, Q., & Ji, J. (2014) · Journal of Proteomics · doi:10.1016/j.jprot.2014.07.028 · Cited by 38
“tein E (ApoE), CD36, CD47, advanced glycation end products receptor (RAGE), neprilysin (NEP), angiotensin-converting enzyme-1 (ACE-1), and endothelin-converting enzyme-2 (ECE-2) [16,19,22–26].”
BackgroundPhagocytic Glial Cells in Brain Homeostasis
Kono, R., Ikegaya, Y., & Koyama, R. (2021) · Cells · doi:10.3390/cells10061348 · Cited by 40
Shen, Y., Liu, F., & Zhang, M. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117235 · Cited by 36
CD47 in the Brain and Neurodegeneration: An Update on the Role in Neuroinflammatory Pathways
Gheibihayat, S. M., Cabezas, R., Nikiforov, N. G., Jamialahmadi, T., Johnston, T. P., & Sahebkar, A. (2021) · Molecules · doi:10.3390/molecules26133943 · Cited by 34
“During neurological disorders, CD47 functions as a key neuroimmune modulator responding to chronic and acute CNS injuries and in the process of recovery [5,8].”
BackgroundLinking T cells to Alzheimer's disease: from neurodegeneration to neurorepair
Bryson, K. J., & Lynch, M. A. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.10.003 · Cited by 33
“Ab also impacts on glial function; it activates both microglia and astrocytes in vitro triggering production and release of proinflammatory cytokines [3], and reactive oxygen and nitrogen species, all of which can have a detrimental effect on neuronal function [4].”
BackgroundSelf-citationAhn, E. H., & Park, J. (2025) · Cells · doi:10.3390/cells14020089 · Cited by 36
“In the early phases of AD, microglia activated by A β attempt to eliminate A β deposits by inducing CD36 expression and stimulating phagocytosis in astrocytes and microglia [103,107,108].”
An Overview of Astrocyte Responses in Genetically Induced Alzheimer’s Disease Mouse Models
Spanos, F., & Liddelow, S. A. (2020) · Cells · doi:10.3390/cells9112415 · Cited by 32
Astrocytes: From the Physiology to the Disease
Trujillo‐Estrada, L., Gómez-Arboledas, Á., Forner, S., Martini, A. C., Gutiérrez, A., Baglietto‐Vargas, D., & LaFerla, F. M. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190830110152 · Cited by 30
The Role of Glial Mitochondria in α-Synuclein Toxicity
Jeon, Y., Kwon, Y., Jo, M., Lee, S., Kim, S., & Kim, H. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.548283 · Cited by 31
“Accumulating evidence suggests that the loss of proper phagocytic functions in astrocytes may contribute to neurodegenerative processes (Jones et al., 2013; Tong et al., 2014; Chung et al., 2016).”
BackgroundSoden, P. A., Henderson, A. R., & Lee, E. (2022) · Advanced Biology · doi:10.1002/adbi.202200027 · Cited by 32
Inhibition of JAK2 attenuates the increase in inflammatory markers in microglia from APP/PS1 mice
Jones, R. S., Minogue, A. M., Fitzpatrick, O. M., & Lynch, M. A. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.04.018 · Cited by 28
“Primary microglia were prepared from brains of 1-day-old neonatal mice (Bioresources Unit, Trinity College, Dublin, Ireland) as described previously (Jones et al., 2013).”
Self-citationGabrielli, M., Tozzi, F., Verderio, C., & Origlia, N. (2022) · Cells · doi:10.3390/cells12010063 · Cited by 33
McManus, R. M., Finucane, O. M., Wilk, M. M., Mills, K. H. G., & Lynch, M. A. (2017) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-017-9753-6 · Cited by 28
Self-citationLü, L., Liu, X., Fu, J., Liang, J., Hou, Y., & Dou, H. (2022) · Scientific Reports · doi:10.1038/s41598-022-10973-8 · Cited by 26
Cornejo, F., & Rommy von Bernhardi, M. (2013) · Mediators of Inflammation · doi:10.1155/2013/895651 · Cited by 25
“[81] R.”
BackgroundLasič, E., Galland, F., Vardjan, N., Šribar, J., Križaj, I., Leite, M., Zorec, R., & Stenovec, M. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13754 · Cited by 24
Hassan, H., Rawlinson, C., Lan, Y., Jenkins, S. I., & Chen, R. (2025) · Biomolecules · doi:10.3390/biom15111629 · Cited by 28
CD47 deficiency improves neurological outcomes of traumatic brain injury in mice
Zhao, S., Yu, Z., Liu, Y., Bai, Y., Jiang, Y., van Leyen, K., Yang, Y., Lok, J. M., Whalen, M. J., Lo, E. H., et al. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.12.006 · Cited by 25
Astrocytic MicroRNA in Ageing, Inflammation, and Neurodegenerative Disease
Chu, A. J., & Williams, J. M. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2021.826697 · Cited by 22
“Altered expression of several miRNA has been observed, however, in both primary astrocytes and ADEVs from the SOD1G93A (mSOD1) mouse model of ALS (Gomes et al., 2019, 2020), though, curiously, others found no differences in ADEV cargo between mSOD1 and wildtype mice (Jovičić and Gitler, 2017).”
BackgroundTondera, C., Laube, M., & Pietzsch, J. (2016) · Amino Acids · doi:10.1007/s00726-016-2349-2 · Cited by 21
“Another hypothesis that could be deduced from our data will attribute participation of CD36 in forming clusters of various pattern recognition receptors, including RAGE and/or Toll-like receptors (Drage et al. 2009; Jimenez-Dalmaroni et al. 2009; Xanthis et al. 2009; Jones et al. 2013).”
BackgroundEltony, S. A., & Abdelhameed, S. Y. (2017) · Tissue and Cell · doi:10.1016/j.tice.2017.01.006 · Cited by 21
Chilumuri, A., Odell, M., & Milton, N. G. N. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400146a · Cited by 20
Simons, E. S., Smith, M. A., Crish, S. D., & Crish, S. D. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105146 · Cited by 19
Byun, Y. G., & Chung, W. (2018) · Journal of Visualized Experiments · doi:10.3791/56647 · Cited by 18
Yang, X., Wang, Y., Qiao, Y., Lin, J., Lau, J. K. Y., Fu, W., Fu, A. K. Y., & Ip, N. Y. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2420324122 · Cited by 17
Daschil, N., & Humpel, C. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00075 · Cited by 18
“It has been shown that reactive astrocytes are capable of phagocytosing Aβ deposits or dead cells after brain injury and thereby protecting surrounding healthy neurons from cell death (Wyss-Coray et al., 2003; Lööv et al., 2012; Jones et al., 2013).”
BackgroundInfluentialKomatsu, A., Iida, I., Nasu, Y., Ito, G., Harada, F., Kishikawa, S., Moss, S. J., Maeda, T., & Terunuma, M. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101933 · Cited by 16
Alzheimer's disease/dementia-associated brain pathology in aging DPP6-KO mice
Lin, L., Petralia, R. S., Holtzclaw, L. A., Wang, Y., Abebe, D. T., & Hoffman, D. A. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105887 · Cited by 17
Lana, D., Ugolini, F., & Giovannini, M. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249441 · Cited by 17
Zhuang, J., Zhang, Y., Shu, H., Zhang, S., Zhao, W., Ward, N., & Wang, J. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03133-6 · Cited by 17
Pomilio, C. J., Presa, J., Oses, C., Vinuesa, A., Bentivegna, M., Gregosa, A., Riudavets, M. A., Sevlever, G. E., Galván, V., Levi, V., et al. (2024) · Molecular Neurobiology · doi:10.1007/s12035-023-03897-5 · Cited by 15
Hirota, Y., Sakakibara, Y., Morishima, M., Sano, T., Hara, M., Arakawa, A., Takao, M., Murayama, S., Saito, Y., Sekiya, M., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116203 · Cited by 13
MyD88 acts as an adaptor protein for inflammatory signalling induced by amyloid-β in macrophages
O’Halloran, S., O’Leary, A., Kuijper, T., & Downer, E. J. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.08.001 · Cited by 13
Glial phagocytosis for synapse and toxic proteins in neurodegenerative diseases
Choi, Y., & Chung, W. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00870-9 · Cited by 14
“Furthermore, blocking these receptors significantly reduces the phagocytic capacity of astrocytes [93].”
Cheloha, R. W., Li, Z., Bousbaine, D., Woodham, A. W., Perrin, P., Volarić, J., & Ploegh, H. L. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00493 · Cited by 12
Takano-Kawabe, K., Matoba, K., Nakamura, Y., & Moriyama, M. (2023) · Neurochemical Research · doi:10.1007/s11064-023-04022-7 · Cited by 10
“Several candidate molecules for Aβ uptake were reported; LRP, receptor of advanced glycation end product (RAGE), CD36 and CD47 [59].”
Cullen, P., Gammerdinger, W., Sui, S. J. H., Mazumder, A. G., & Sun, D. (2024) · Glia · doi:10.1002/glia.24571 · Cited by 15
“We detected significant transcriptional enrichment of phagocytosis-associated TAM family members Tyro3 and Axl , complement factor C4b , and the scavenger receptor Cd36 in our within-retina comparison (Jones et al., 2013; Konishi et al., 2022).”
Metadata
- Authors
- Jones, R. S., Minogue, A. M., Connor, T. J., & Lynch, M. A.
- Affiliations
- Trinity College Dublin (IE)
- Corresponding author
- Minogue, Aedín M.
- ORCID
- Lynch, Marina A.
- Venue
- Journal of Neuroimmune Pharmacology
- Published
- 2012-12-14
- Volume
- 8
- Issue
- 1
- Pages
- 301-311
- ISSN
- 1557-1890 (ISSN-L)
- 1557-1904
- OpenAlex
- W2036955747
- Cited by
- 147
- References
- 46
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 10 · 2023: 9 · 2022: 13 · 2021: 19 · 2020: 17 · 2019: 6 · 2018: 7 · 2017: 15 · 2016: 12 · 2015: 7 · 2014: 15 · 2013: 2
- FWCI
- 3.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Neuroimmune Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Health Research Board
- Science Foundation Ireland
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- amyloid-beta, astrocytes, phagocytosis, CD36, CD47, RAGE, actin polymerization, microglia, receptor-mediated phagocytosis, receptor antagonists, neuroinflammation
- MeSH terms
- Receptor for Advanced Glycation End Products, Animals, Animals, Newborn, Astrocytes, Cell Survival, Flow Cytometry, Fluorescent Dyes, Glial Fibrillary Acidic Protein, L-Lactate Dehydrogenase, Microspheres, Phagocytosis, Receptors, Immunologic, RNA, Messenger, Amyloid beta-Peptides, Fluorescein-5-isothiocyanate, Rats, Wistar, Microglia, CD36 Antigens, Excitatory Amino Acid Transporter 2, CD11b Antigen, Rats, CD47 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review